| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |